199 related articles for article (PubMed ID: 29571225)
41. Gremlin-1 potentiates the dedifferentiation of VSMC in early stages of atherosclerosis.
Silvério de Barros R; Dias GS; Paula do Rosario A; Paladino FV; Lopes GH; Campos AH
Differentiation; 2019; 109():28-33. PubMed ID: 31494396
[TBL] [Abstract][Full Text] [Related]
42. Pioglitazone, a PPARγ agonist, attenuates PDGF-induced vascular smooth muscle cell proliferation through AMPK-dependent and AMPK-independent inhibition of mTOR/p70S6K and ERK signaling.
Osman I; Segar L
Biochem Pharmacol; 2016 Feb; 101():54-70. PubMed ID: 26643070
[TBL] [Abstract][Full Text] [Related]
43. Stanozolol promotes lipid deposition in the aorta through an imbalance in inflammatory cytokines and oxidative status in LDLr knockout mice fed a normal diet.
de Andrade TU; Haguihara SCGC; Falsoni RMP; da Silva CL; Dubois Filho DG; de Souza Andrade Moraes F; do Nascimento AM; Brasil GA; de Lima EM
Basic Clin Pharmacol Toxicol; 2019 Apr; 124(4):360-369. PubMed ID: 30295413
[TBL] [Abstract][Full Text] [Related]
44. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
[TBL] [Abstract][Full Text] [Related]
45. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
46. Apocynum leaf extract inhibits the progress of atherosclerosis in rats via the AMPK/mTOR pathway.
Lü L; Zhang D; Sun B; Hu Y; Yan M; Liu K; Li X; Ren L
Pharmazie; 2017 Jan; 72(1):41-48. PubMed ID: 29441896
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of Herp alleviates hyperhomocysteinemia mediated atherosclerosis through the inhibition of vascular smooth muscle cell phenotype switching.
Lin H; Ni T; Zhang J; Meng L; Gao F; Pan S; Luo H; Xu F; Ru G; Chi J; Guo H
Int J Cardiol; 2018 Oct; 269():242-249. PubMed ID: 30017525
[TBL] [Abstract][Full Text] [Related]
48. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1.
Ha JM; Yun SJ; Kim YW; Jin SY; Lee HS; Song SH; Shin HK; Bae SS
Biochem Biophys Res Commun; 2015 Aug; 464(1):57-62. PubMed ID: 26032503
[TBL] [Abstract][Full Text] [Related]
49. Anti-atherosclerotic effect of Longxuetongluo Capsule in high cholesterol diet induced atherosclerosis model rats.
Zhou JM; Wang HM; Lv YZ; Wang ZZ; Xiao W
Biomed Pharmacother; 2018 Jan; 97():793-801. PubMed ID: 29112932
[TBL] [Abstract][Full Text] [Related]
50. NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis.
Vendrov AE; Sumida A; Canugovi C; Lozhkin A; Hayami T; Madamanchi NR; Runge MS
Redox Biol; 2019 Feb; 21():101063. PubMed ID: 30576919
[TBL] [Abstract][Full Text] [Related]
51. Vitamin K2 can suppress the expression of Toll-like receptor 2 (TLR2) and TLR4, and inhibit calcification of aortic intima in ApoE
Wang Z; Wang Z; Zhu J; Long X; Yan J
Vascular; 2018 Feb; 26(1):18-26. PubMed ID: 28587577
[TBL] [Abstract][Full Text] [Related]
52. Musashi-2 binds with Fbxo6 to induce Rnaset2 ubiquitination and chemokine signaling pathway during vascular smooth muscle cell phenotypic switch in atherosclerosis.
Zhang T; Wu S; Xu R; Zhang S; Wang M; Li J
Cell Signal; 2023 Nov; 111():110869. PubMed ID: 37633478
[TBL] [Abstract][Full Text] [Related]
53. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
54. TRPV1 activation inhibits phenotypic switching and oxidative stress in vascular smooth muscle cells by upregulating PPARα.
Zhou Y; Wang X; Guo L; Chen L; Zhang M; Chen X; Li J; Zhang L
Biochem Biophys Res Commun; 2021 Mar; 545():157-163. PubMed ID: 33550097
[TBL] [Abstract][Full Text] [Related]
55. Ferulic Acid Alleviates Atherosclerotic Plaques by Inhibiting VSMC Proliferation Through the NO/p21 Signaling pathway.
Wu X; Hu Z; Zhou J; Liu J; Ren P; Huang X
J Cardiovasc Transl Res; 2022 Aug; 15(4):865-875. PubMed ID: 34993756
[TBL] [Abstract][Full Text] [Related]
56. oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.
Kiyan Y; Tkachuk S; Hilfiker-Kleiner D; Haller H; Fuhrman B; Dumler I
J Mol Cell Cardiol; 2014 Jan; 66():72-82. PubMed ID: 24239845
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory effects of tanshinone IIA on atherosclerostic vessels of ovariectomized ApoE mice are mediated by estrogen receptor activation and through the ERK signaling pathway.
Liu X; Guo CY; Ma XJ; Wu CF; Zhang Y; Sun MY; Pan YT; Yin HJ
Cell Physiol Biochem; 2015; 35(5):1744-55. PubMed ID: 25832326
[TBL] [Abstract][Full Text] [Related]
58. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of 5-Hydroxytryptamine Receptor 2B Reduced Vascular Restenosis and Mitigated the β-Arrestin2-Mammalian Target of Rapamycin/p70S6K Pathway.
Liu Y; Wang Z; Li J; Ban Y; Mao G; Zhang M; Wang M; Liu Y; Zhao B; Shen Q; Xu Q; Wang N
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29382665
[TBL] [Abstract][Full Text] [Related]
60. Temporal and spatial changes of peroxiredoxin 2 levels in aortic media at very early stages of atherosclerotic lesion formation in apoE-knockout mice.
Kato R; Hayashi M; Aiuchi T; Sawada N; Obama T; Itabe H
Free Radic Biol Med; 2019 Jan; 130():348-360. PubMed ID: 30395970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
